The Institute of Bioengineering and Bioimaging (IBB) is located in Singapore's research and development hub for biomedical sciences, at the heart of Biopolis. The institute is located at Helios and Nanos and is staffed by imaging experts, bioengineers, chemists, physicists, biologists and clinicians. IBB integrates the capabilities and technologies built up by the Institute of Bioengineering and Nanotechnology (IBN) and Singapore Bioimaging Consortium (SBIC), which were established in 2003 and 2004 respectively. IBB's work includes the following scientific breakthroughs and innovations:
Biomedical Devices & Diagnostics
Biophotonics & Bioimaging
IBB spearheads multi-disciplinary, application-driven research at the interface of biology, chemistry, engineering and medicine, and work closely with stakeholders across the ecosystem to deliver innovative solutions in strategic areas such as cancer, infectious diseases, and food and nutrition.
Congratulations to Dr Yi Yan Yang and team on being awarded the Wellcome Leap R3 Programme Contract. They are part of a team of scientists in Singapore that are looking to address the limitations of mRNA vaccines.
The work of Lucence, a spin-off company from IBB that
recently made headlines for COVID-19 pre-departure saliva testing. We
spoke to one of our scientists, Dr Rachel Sim, who reflected on her
contribution to the project.
Finding the balance between work and life outside the lab can be challenging for some, but it is important for maintaining good mental health. Speaking to one of our research officers, Rachel Tan, we learn how she makes time for the things that she enjoys outside of work.
Heartiest congratulations to the 2021 cohort A*STAR scholars and warmly welcomes these talents to our A*STAR family!
RSVP to join the the award ceremony event today!